Prevalence, Associated Factors, and Impact on Quality of Life of Migraine in a Community in Northeast China

Aims: To validate the Chinese version of the Identification of Migraine screener (ID-Migraine), assess migraine prevalence, identify potential associated factors, and assess the impact of migraine on quality of life in a community in Harbin, PR China. Methods: A community-based, cross-sectional study was conducted in the Songbei district of Harbin. After excluding the people who did not usually reside in the community, 2,588 adults were invited to participate in the study. Eligible participants underwent a physical examination before completing a questionnaire addressing demographics, medical history, and other features. Additionally, the ID-Migraine was validated by using International Classification of Headache Disorders-3 criteria, with 94 participants screening positive and 100 participants screening negative for migraine as diagnosed through a telephone interview. The diagnostic accuracy of ID-Migraine was evaluated by sensitivity and specificity, and a multivariate logistic regression model was used to determine the association between migraine and associated factors. Results: A total of 1,143 subjects completed the questionnaire (response rate 44.2%). The prevalence of migraine was 8.9%, with a male to female prevalence ratio of 1:3.30 (3.7% versus 12.2%; P < .001). The sensitivity (90.6%; 95% confidence interval [CI] = 75.0% to 97.9%) and specificity (71.4%; 95% CI = 60.0% to 81.2%) of the ID-Migraine were satisfactory. Multivariate logistic regression analyses suggested female sex, depression, coronary heart disease (CHD), chronic obstructive pulmonary disease (COPD), ischemic stroke (IS), and hypertension were positively associated with migraine, whereas age and education level were negatively associated with migraine. Migraine was shown to significantly impact quality of life. Conclusion: Migraine is a highly prevalent disease that can significantly affect quality of life. Age, sex, education level, depression, CHD, COPD, IS, and hypertension were all associated with migraine.

associated factors; ID-Migraine; migraine; prevalence; quality of life

1. Breslau N, Rasmussen BK. The impact of migraine: Epidemiology, risk factors, and co-morbidities. Neurology 2001;56:S4–S12.

2. Zhao F, Tsay JY, Cheng XM, et al. Epidemiology of migraine: A survey in 21 provinces of the People’s Republic of China, 1985. Headache 1988;28:558–565.

3. Cheng X. Epidemiologic survey of migraine in six cities of China [in Chinese]. Zhonghua Shen Jing Jing Shen Ke Za Zhi 1990; 23:44–46, 64.

4. Yu S, Liu R, Zhao G, et al. The prevalence and burden of primary headaches in China: A population-based door-to-door survey. Headache 2012;52:582–591.

5. Cevoli S, D’Amico D, Martelletti P, et al. Underdiagnosis and undertreatment of migraine in Italy: A survey of patients attending for the first time 10 headache centres. Cephalalgia 2009;29: 1285–1293.

6. Lipton RB, Dodick D, Sadovsky R, et al. A self-administered screener for migraine in primary care: The ID Migraine validation study. Neurology 2003;61:375–382.

7. Rockett FC, de Oliveira VR, Castro K, Chaves ML, Perla Ada S, Perry ID. Dietary aspects of migraine trigger factors. Nutr Rev 2012;70:337–356.

8. Critchley M, Ferguson FR. Migraine. Lancet 1933:123–126.

9. Millichap JG, Yee MM. The diet factor in pediatric and adolescent migraine. Pediatr Neurol 2003;28:9–15.

10. Yang AC, Fuh JL, Huang NE, Shia BC, Peng CK, Wang SJ. Temporal associations between weather and headache: Analysis byempirical mode decomposition. PloS One 2011;6:e14612.

11. Chabriat H, Danchot J, Michel P, Joire JE, Henry P. Precipitating factors of headache. A prospective study in a national control-matched survey in migraineurs and nonmigraineurs. Headache 1999;39:335–338.

12. HKTDC Research. Harbin (Heilongjian) City Information. http://china-trade-research.hktdc.com/business-news/article/Fast-Facts/Harbin-Heilongjiang-City-Information/ff/en/1/1X000000/1X074BKJ.htm. Accessed 4 March 2016.

13. Vos T, Flaxman AD, Naghavi M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2163–2196.

14. Aamodt AH, Stovner L, Midthjell K, Hagen K, Zwart JA. Headache prevalence related to diabetes mellitus. The Head-HUNT Study. Eur J Neurol 2007;14:738–744.

15. Scher AI, Terwindt GM, Picavet HS, Verschuren WM, Ferrari MD, Launer LJ. Cardiovascular risk factors and migraine: The GEM population-based study. Neurology 2005;64:614–620.

16. Davey G, Sedgwick P, Maier W, Visick G, Strachan DP, Anderson HR. Association between migraine and asthma: Matched case-control study. Br J Gen Pract 2002;52:723–727.

17. Harandi SA, Togha M, Sadatnaseri A, Hosseini SH, Jahromi SR. Cardiovascular risk factors and migraine without aura: A case-control study. Iran J Neurol 2013;12:98–101.

18. Schürks M, Rist PM, Bigal ME, Buring JE, Lipton RB, Kurth T. Migraine and cardiovascular disease: Systematic review and meta-analysis. BMJ 2009;339:b3914.

19. Oztora S, Korkmaz O, Dagdeviren N, et al. Migraine headaches among university students using ID migraine test as a screening tool. BMC Neurol 2011;11:103.

20. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961;4: 561–571.

21. Ware JE, Snow KK, Kosinski M, Gandek B. SF-36 Health Survey Manual and Interpretation Guide. Boston: The Health Institute, New England Medical Center, 1993.

22. Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 2013;33:629–808.

23. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Headache Classification Committee of the International Headache Society. Cephalalgia 1988;8(suppl 7):1–96.

24. Huang GB, Yao LT, Hou JX, et al. Epidemiology of migraine in the She ethnic minority group in Fujian province, China. Neurol Res 2013;35:684–692.

25. Sun-Edelstein C, Mauskop A. Foods and supplements in the management of migraine headaches. Clin J Pain 2009; 25:446–452.

26. Wang SJ, Fuh JL, Young YH, Lu SR, Shia BC. Prevalence of migraine in Taipei, Taiwan: A population-based survey. Cephalalgia 2000;20:566–572.

27. Gupta S, Mehrotra S, Villalón CM, Perusquía M, Saxena PR, MaassenVanDenBrink A. Potential role of female sex hormones in the pathophysiology of migraine. Pharmacol Ther 2007;113:321–340.

28. Cheung RT. Prevalence of migraine, tension-type headache, and other headaches in Hong Kong. Headache 2000;40:473–479.

29. Le H, Tfelt-Hansen P, Skytthe A, Kyvik KO, Olesen J. Association between migraine, lifestyle and socioeconomic factors: A population-based cross-sectional study. J Headache Pain 2011;12:157–172.

30. Waldie KE, Hausmann M, Milne BJ, Poulton R. Migraine and cognitive function: A life-course study. Neurology 2002; 59:904–908.

31. Rasmussen BK. Epidemiology of headache. Cephalalgia 2001; 21:774–777.

32. Karakurum B, Soylu O, Karatas¸ M, et al. Personality, depression, and anxiety as risk factors for chronic migraine. Int J Neurosci 2004;114:1391–1399.

33. Merikangas KR, Stevens DE, Merikangas JR, et al. Tyramine conjugation deficit in migraine, tension-type headache, and depression. Biol Psychiatry 1995;38:730–736.

34. Silberstein SD. Shared mechanisms and comorbidities in neurologic and psychiatric disorders. Headache 2001;41(suppl 1): S11–S17.

35. Agostoni E, Aliprandi A. Migraine and hypertension. Neurol Sci 2008;29(suppl 1):S37–S39.

36. Benseñor IM, Goulart AC, Lotufo PA, Menezes PR, Scazufca M. Cardiovascular risk factors associated with migraine among the elderly with a low income: the Sao Paulo Ageing & Health Study (SPAH). Cephalalgia 2011;31:331–337.

37. Blau JN, Kell CA, Sperling JM. Water-deprivation headache: A new headache with two variants. Headache 2004;44:79–83.

38. Terwindt GM, Ferrari MD, Tijhuis M, Groenen SM, Picavet HS, Launer LJ. The impact of migraine on quality of life in the general population: The GEM study. Neurology 2000;55:624–629.

39. Hill JM, Zalos G, Halcox JP, et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl JMed 2003;348:593–600.

40. Lee ST, Chu K, Jung KH, et al. Decreased number and function of endothelial progenitor cells in patients with migraine. Neurology 2008;70:1510–1517.

41. Wang X, San YZ, Sun JM, et al. Validation of the Chinese version of ID-Migraine in medical students and systematic review with meta-analysis concerning its diagnostic accuracy. J Oral Facial Pain Headache 2015;29:265–278.